Lifevantage Corp (LFVN) — Institutional Holders & Catalysts | BiotechEdge

Catalysts Convergence Compare Insiders Runway Research

Sign In Start Free Trial

← Back to home

Lifevantage Corp

LFVN

Held by 1 specialist biotech fund

Fund Holdings

B

BiotechEdge

Catalysts Convergence Insiders Cash Runway Research Pricing

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Support Terms Privacy Disclaimer

Driehaus Capital

Position Trend

May 15, 2025

$6.7M

1 fund

Aug 14, 2025

$0

0 funds

Nov 14, 2025

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 4 quarters

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalEXITFeb 17, 2026

Shares: 0Value: N/A

Driehaus CapitalEXITNov 14, 2025

Shares: 0Value: N/A

Driehaus CapitalEXIT

0 shares$0

Driehaus CapitalNEW

459,619 shares$6.7M

+ 2more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

WLDN1 fund PTN1 fund ONTO1 fund VALE1 fund LASR1 fund TKO1 fund TNL1 fund TNDM1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: